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Background: Single nucleotide polymorphisms (SNPs) in genes derived from distinct pathways are associated with
a breast cancer risk. Identifying possible SNP-SNP interactions in genome-wide case–control studies is an important
task when investigating genetic factors that influence common complex traits; the effects of SNP-SNP interaction
need to be characterized. Furthermore, observations of the complex interplay (interactions) between SNPs for
high-dimensional combinations are still computationally and methodologically challenging. An improved branch
and bound algorithm with feature selection (IBBFS) is introduced to identify SNP combinations with a maximal
difference of allele frequencies between the case and control groups in breast cancer, i.e., the high/low risk
combinations of SNPs.
Results: A total of 220 real case and 334 real control breast cancer data are used to test IBBFS and identify
significant SNP combinations. We used the odds ratio (OR) as a quantitative measure to estimate the associated
cancer risk of multiple SNP combinations to identify the complex biological relationships underlying the
progression of breast cancer, i.e., the most likely SNP combinations. Experimental results show the estimated odds
ratio of the best SNP combination with genotypes is significantly smaller than 1 (between 0.165 and 0.657) for
specific SNP combinations of the tested SNPs in the low risk groups. In the high risk groups, predicted SNP
combinations with genotypes are significantly greater than 1 (between 2.384 and 6.167) for specific SNP
combinations of the tested SNPs.
Conclusions: This study proposes an effective high-speed method to analyze SNP-SNP interactions in breast cancer
association studies. A number of important SNPs are found to be significant for the high/low risk group. They can
thus be considered a potential predictor for breast cancer association.Background
At present, identifying SNP-SNP interactions in genome-
wide case–control studies is computationally and methodo-
logically challenging [1]. To better understand the complex
disease characteristics in case–control studies, we extended
previous research of a breast cancer study and simul-
taneously explored single nucleotide polymorphism (SNP)
combinations in low and high risk groups [2]. In complex
diseases and cancers, joint genetic effects (epistasis) across
the whole genome need to be considered. In a recent study,
Phillips identifies three types of epistasis: compositional
epistasis, statistical epistasis and functional epistasis [3].
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reproduction in any medium, provided the oranother at a different locus, statistical epistasis constitutes a
statistical deviation from the additive effects of two loci on
the phenotype, and functional epistasis addresses molecular
interactions [3,4].
Many methods have been developed to detect epistasis
on the basis of a statistical definition to explore gene-
gene interactions or SNP-SNP interactions (epistasis) in
complex diseases; these include logic regression [5,6],
Multifactor-Dimensionality Reduction (MDR) [7], Poly-
morphism Interaction Analysis (PIA) [8], Bayesian
model selection [9], SNPruler [10], random jungle [11],
genetic algorithms [12] and other methods [13-16]. The
challenges posed by traditional parametric statistical
methods (e.g., logistic regression models) have been
detailed in Hahn [6]. The MDR method is inspired by
the combinatorial partitioning method, in which a data-
reduction method effectively reduces the genotypel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the computational load can be excessive when dealing
with more than 10 polymorphisms [17]. PIA uses a case-
based exclusion for missing SNP data, i.e., only those
subjects for which all SNPs are identified (in a particular
combination) are used in the analysis. SNPruler is a statis-
tical method for identifying SNP combinations; it uses the
Chi-square test to design the bound in the original Branch
and Bound algorithm. Unlike our study, which focuses on
the difference between cases and controls, SNPruler fo-
cuses on the ratio between cases and controls. Although
these methods are widely used, they can still be improved
upon. As a test data set increases in size, the run time
increases exponentially with the order of interaction.
However, few studies address SNP-SNP interactions for
multiple SNPs. Hence, when a data set is sufficiently large,
selecting an appropriate method becomes important.
This study proposes a method based on statistical
epistasis and an improved branch and bound algorithm
combined with feature selection (IBBFS) to explore
combinations of SNP-SNP interactions in a breast can-
cer association study. The proposed method can reduce
the search time and accurately determine the difference
between cases and controls in low and high risk groups.
Finally, we use the odds ratio (OR) as a quantitative
measure to assess combinations of SNPs in the case–
control studies. The odds ratio is a commonly-usedTable 1 Estimated best combinations of two SNPs on the occ
Combined SNP number
(specific SNPs)
SNP Genotypes Control number / Case
High-risk Two SNPs Other 330/209
SNPs (4, 7) 2-3 4/11
(Diff. = 7)
Two SNPs Other 327/209
SNPs (4, 6) 3-2 7/11
(Diff. = 4)
Two SNPs Other 289/172
SNPs (3, 5) 2-1 45/48
(Diff. = 3)
Low-risk Two SNPs Other 197/151
SNPs (3, 4) 1-1 137/69
(Diff. = 68)
Two SNPs Other 226/174
SNPs (3, 7) 1-2 108/46
(Diff. = 62)
Two SNPs Other 223/168
SNPs (1, 3) 2-1 111/52
(Diff. = 59)
NOTE - Other: The reference group, indicating the union of all other possible two to
SP: Specificity.statistic that expresses the strength of association be-
tween exposure and disease [18-20]. Experimental
results show that the IBBFS method can determine risk
factors in breast cancers.
Results
Identification of best SNP-SNP interaction combinations
with maximal difference between cases and controls
The IBBFS method was used to find the best combin-
ation of SNPs in the high and low risk groups, with the
best combinations of two-SNP interaction results
shown in Table 1. We sorted the combinations of the
two-SNP results and selected the top three maximum
difference combinations in the low and high risk
groups. In Table 1, the six specific SNP combinations
with their corresponding genotypes (i.e., the SNPs (4, 7)
with genotype (2–3) [CXCL12 (rs1801157)-AG]-[KITLG
(rs10506957)-CC]) showed a maximal difference value of
7 between the 4 samples in the control data and the 11
samples in the high risk case data groups. The SNPs (3, 4)
with genotype (1–1), [CXCR4 (rs2228014)-CC]-[CXCL12
(rs1801157)-GG], showed a maximal difference value of
68 between the 137 samples in the control data and the
69 samples in low risk case data groups. SNPs (4, 7) with
genotype (2–3) and SNPs (3, 4) with genotype (1–1) are
statistically significant because their p-value is smaller
than 0.05. We then extended the best results of the two-urrence of breast cancer
number CC SN SP Average Odds Ratio (95%CI) p-value
0.616 0.050 0.988 0.551 4.342 (1.259-16.394) 0.013
0.610 0.050 0.979 0.546 2.459 (0.867-7.143) 0.084
0.608 0.218 0.865 0.564 1.792 (1.118-2.875) 0.014
0.480 0.314 0.589 0.461 0.657 (0.452-0.955) 0.025
0.491 0.209 0.676 0.459 0.553 (0.364-0.839) 0.004
0.496 0.236 0.668 0.467 0.622 (0.415-0.931) 0.017
seven SNP combinations; N.E: Not estimable; CC: Correct; SN: Sensitivity;
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combinations are extended until the maximum number of
SNPs was reached.
Finally, we used IBBFS to find the best-performing
combinations of three or more SNPs, with results
shown in Tables 2 and 3. Table 2 shows the maximum
difference combinations (two to seven SNPs) for the
high risk category. These respective combinations are
SNPs (4, 7) with genotypes (2–3) and an OR of 4.342,
SNPs (3, 5, 6) with genotypes (2-1-1) and an OR of
2.384, SNPs (3, 4, 5, 6) with genotypes (2-1-1-1) and an
OR of 3.024, and SNPs (1, 3, 4, 5, 6) with genotypes (1-
2-1-1-1) and an OR of 3.133. These two-to-five SNP
combinations are statistically significant with a p-value
smaller than 0.05. However, for combinations of six
SNPs and combinations of seven SNPs, the p-value is
greater than 0.05. In Table 3, the results for SNPs (3, 4)
with genotypes (1–1), SNPs (1, 3, 5) with genotypes
(2-1-1), SNPs (1, 2, 3, 4) with genotypes (2-2-1-1), and
SNPs (1, 2, 3, 4, 5) with genotypes (2-2-1-1-1) all have a
p-value smaller than 0.05. For all other combinations of
SNPs the p-value was greater than 0.05. These experi-
mental results prove that the proposed IBBFS method
can handle combinations of multiple SNPs and deter-
mine the best combination of two to seven SNPs, both








Two SNPs Other 330/209
SNPs (4, 7) 2-3 4/11 0.615
(Diff. = 7)
Three SNPs Other 314/191
SNPs (3, 5, 6) 2-1-1 20/29 0.619
(Diff. = 9)
Four SNPs Other 325/203
SNPs (3, 4, 5, 6) 2-1-1-1 9/17 0.617
(Diff. = 8)
Five SNPs Other 329/210
SNPs (1, 3, 4, 5, 6) 1-2-1-1-1 5/10 0.612
(Diff. = 5)
Six SNPs Other 332/214
SNPs (1, 2, 3, 5, 6, 7) 1-2-2-1-1-2 0/4 0.610
(Diff. = 4)
Seven SNPs Other 333/216
SNPs (1, 2, 3, 4, 5, 6, 7) 2-2-2-1-1-1-1 1/4 0.608
(Diff. = 3)
NOTE - Other: The reference group, indicating the union of all other possible two to
SP: Specificity.Analysis of combinations of SNP (4, 7) and combinations
of SNP (3, 4) in breast cancer
First, we analyzed the high risk combination of SNP (4, 7)
in breast cancer. Information related to the SNP (4, 7) com-
bination and the OR results are shown in Table 4, while
Figure 1 displays a bar graph illustrating the OR value. Two
SNPs are shown in a 3 × 3 table that represents nine state
combinations. IBBFS shows that SNP (4, 7) with genotype
(2–3) with a maximal OR value of 4.342 (p-value < 0.05)
has a maximal difference of 7 between the case and control
groups. We observe that, for other combinations of SNP
(4, 7) with genotype (1–2), the OR value is at a minimum
and the p-values are statistically significant (p-value < 0.05).
Hence, only two combinations of SNP (4, 7) in the 3 × 3
table are statistically significant (p-value < 0.05).
Secondly, we analyzed the low risk combinations of
SNP (3, 4), with the related information and OR results
shown in Table 5. The bar graphs in Figure 2 illustrate
the OR value. When the combination of SNP (3, 4) with
genotype (1–1) is chosen, the minimum OR value is
0.657 (p-value < 0.05). Here, the maximum difference
also is SNP (3, 4) with genotype (1–1), with a difference
of 68 between cases and controls. When considering
combinations of more SNPs, the frequently occurring
combinations of two SNPs in the following combinations
are important.ce of breast cancer in the high risk group
SN SP Average Odds Ratio (CI) p-value
0.050 0.988 0.551 4.342 (1.259-16.934) 0.013
0.132 0.940 0.564 2.384 (1.263-4.518) 0.005
0.077 0.973 0.556 3.024 (1.246-7.491) 0.008
0.045 0.985 0.547 3.133 (0.969-10.680) 0.031
0.018 1.000 N.E
0.014 0.997 0.540 6.167 (0.648-145.871) 0.084
seven SNP combinations; N.E: Not estimable; CC: Correct; SN: Sensitivity;







CC SN SP Average Odds Ratio (CI) p-value
Two SNPs Other 197/151
SNPs (3, 4) 1-1 137/69 0.480 0.314 0.600 0.465 0.657 (0.452-0.955) 0.025
(Diff. = 68)
Three SNPs Other 260/189
SNPs (1, 3, 5) 2-1-1 74/31 0.525 0.141 0.778 0.481 0.576 (0.355-0.934) 0.020
(Diff. = 43)
Four SNPs Other 294/207
SNPs (1, 2, 3, 4) 2-2-1-1 40/13 0.554 0.059 0.880 0.498 0.462 (0.228-0.919) 0.018
(Diff. = 27)
Five SNPs Other 310/215
SNPs (1, 2, 3, 4, 5) 2-2-1-1-1 24/5 0.569 0.023 0.928 0.507 0.300 (0.099-0.846) 0.011
(Diff. = 19)
Six SNPs Other 323/218
SNPs (1, 2, 3, 4, 5, 6) 2-2-1-1-1-2 11/2 0.587 0.009 0.967 0.521 0.269 (0.041-1.301) 0.070
(Diff. = 9)
Seven SNPs Other 325/219
SNPs (1, 2, 3, 4, 5, 6, 7) 2-2-1-1-1-2-1 9/1 0.588 0.005 0.973 0.522 0.165 (0.008-1.277) 0.098
(Diff. = 8)
NOTE - Other: The reference group, indicating the union of all other possible two to seven SNP combinations; N.E: Not estimable; CC: Correct; SN: Sensitivity;
SP: Specificity.
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Tables 2 and 3 show the estimated effects (CC, SN, SP,
OR and 95% CI) of certain specific SNP combinations
on the occurrence of breast cancer. These specific SNP
combinations (two to seven SNPs) had a 0.657 to 0.165Table 4 Odds ratio (OR) (95% CI) (p-value) for SNP




KITLG* TT OR a 1.047 1.163 1.685
Genotypes (Y) CI 0.709-1.546 0.763-1.773 0.706-4.030
p-value 0.849 0.471 0.214
(Ca./Co.) (66/97) (54/73) (13/12)
CT OR a 0.460 0.823 0.499
CI 0.265-0.793 0.503-1.341 0.106-2.034
p-value 0.003 0.484 0.379
(Ca./Co.) (22/65) (33/59) (3/9)




NOTE - *:SNPs (4, 7) pair with its corresponding genotypes CXCL12-rs1801157-
genotype X and KITLG-rs10506957-genotype Y; a: OR in reference to the other
group (1.000); CI: Confidence Interval; Ca.: case; Co.: control; N.E: Not estimable.
Figure 1 SNPs (4, 7) with their corresponding genotypes
CXCL12-rs1801157 and KITLG-rs10506957.
Table 5 Odds ratio (OR) (95% CI) (p-value) for SNP




KITLG * GG OR a 0.657 1.557 1.528
Genotypes (Y) CI 0.459-0.940 0.936-2.590 0.414-5.636
p-value 0.025 0.110 0.719
(Ca./Co.) (69/137) (33/34) (4/4)
AG OR a 1.092 1.222 1.012
CI 0.757-1.576 0.712-2.098 0.201-5.111
p-value 0.639 0.484 1.000
(Ca./Co.) (70/100) (26/33) (2/3)




NOTE - *: SNPs (3, 4) pair with its corresponding genotypes CXCR4-rs2228014
-genotype X and KITLG-rs10506957-genotype Y; a: OR in reference to the other
group (1.000); CI: Confidence Interval; Ca.: case; Co.: control; N.E: Not estimable.
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SNP combinations (two to seven SNPs) also show a
higher risk (OR > 1) of breast cancer in Table 2. When
the OR value is larger than 1, the proportion of subjects
with breast cancer is higher. On the other hand, when
the proportion of subjects with breast cancer is smaller
than 1, the OR values are lower than 1.Figure 2 SNPs (3, 4) with their corresponding genotypes
CXCR4-rs2228014 and CXCL12-rs1801157.Discussions
Identification of SNP-SNP interactions (epistasis) is an
important task [13,21] when exploring a cancer or
disease risk [22-25]. At present, artificial intelligence
(AI) algorithms are rarely used to identify SNP-SNP
interaction combinations. Although some methods have
previously been used to identify SNP combinations
(e.g., MDR [7], machine learning [26], particle swarm
optimization (PSO) [27], and genetic algorithms (GA)
[12], these methods can still be improved upon. MDR,
for example, has three distinct disadvantages. First, the
method is prone to false positive and false negative
errors when the ratio of the number of cases and
controls in a combination of genotypes is similar to that
in the entire data set. Secondly, MDR binary classifi-
cation does not provide any quantitative measure of the
disease risk for each combination of genotypes, but
rather provides a binary measure (high or low) of the
disease risk. The MDR method also does not permit com-
parison of disease risks between different combinations of
genotypes [19]. The machine learning method also has a
drawback in that it does not provide a quantitative meas-
ure of the disease risk for each combination of genotypes.
PSO and GA do not guarantee that the best SNP combin-
ation can be found (see results in Table 6) since both
algorithms use randomly generated initial values and set
an arbitrary number of iterations. If the maximum num-
ber of iterations set as a termination condition is reached
before an optimal solution is found, the PSO and GA
algorithms stop the search prematurely. IBBFS, however,
can overcome all of the above problems.
We focus on understanding the breast cancer risk of
functionally-relevant joint effects of combinatorial SNPs
within and between different cancer pathways. We
calculated the same data set by exhaustive search (ES)
using two to seven SNP combinations to find SNP
interactions which determine an optimal solution.
These calculations were rather time-consuming and the
ES method of calculating combinations of SNPs is thus
impracticable for large data sets. From a practical stand-
point, the main difference between the aforementioned
methods is the computational time required to reach anTable 6 The representative difference of the













SNPs (3,4) (1–1) 137/69 68 7 7
SNPs (3,7) (1–2) 108/46 62 2 1
SNPs (3,5) (1–1) 162/103 59 1 2
NOTE - SNPs (3, 4) represents the combination of SNP3-SNP4, i.e., rs2228014 -
rs1801157. Other combinations follow the same pattern. SNP Genotype (1–1)
represent the SNP genotype (CC – GG) combinations. PSO: particle swarm
optimization; GA: genetic algorithm.
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faster for a high order of interaction combinations by
cutting off unnecessary paths. IBBFS guarantees that
each result contains an optimal solution through the use
the integrated feature selection method. The selected
number of features is r = n-m + 1, where r is the number
of features used, and n and m are the total number of
SNPs and the number of selected SNPs, respectively.
Examples of the ES and IBBFS calculations are respect-
ively shown in Additional file 1: Figure S1 and Additional
file 1: Figure S2. The number of possible solutions
calculated by ES was 30229, whereas IBBFS reduced this
number to 348. IBBFS is thus better suited to deal with
large data sets. IBBFS allows for the investigation of an al-
most unlimited number of SNP combinations, whereas
traditional algorithms are rather limited. The experiments
show that IBBFS has great potential for the identifica-
tion of complex biological relationships among cancer
processes during the development of breast cancer.
Conclusion
This study focused on the selection of SNP combinations
that give a maximal difference between case and control
groups. Evaluating a large number of SNPs associated withTable 7 Baseline characteristics of breast cancer cases and co




1. rs12812942 12 1-AA 174/128
(CD4) 2-AT 141/76 0.482
3-TT 19/16 0.564
2. rs3136685 17 1-GG 107/77
(CCR7) 2-AG 180/114 0.462
3-AA 47/29 0.523
3. rs2228014 2 1-CC 254/151
(CXCR4) 2-CT 73/63 0.586
3-TT 7/6 0.622
4. rs1801157 10 1-GG 175/106
(CXCL12) 2-AG 136/98 0.530
3-AA 23/16 0.597
5. rs3025039 6 1-CC 211/155
(VEGF) 2-CT 117/59 0.498
3-TT 6/6 0.574
6. rs2287074 16 1-GG 164/113
(MMP2) 2-AG 139/93 0.505
3-AA 31/14 0.553
7. rs10506957 12 1-TT 182/133
(KITLG) 2-CT 133/69 0.486
3-CC 19/18 0.568
NOTE - Chr: Chromosome; Control no: number of control; Case no: number of case; Ca disease requires a strategy for focusing on only a select
number of complex interactions. IBBFS was used on
complex SNP-SNP interactions and was demonstrated
to provide the best SNP-SNP interactions for predicting
breast cancer susceptibility. The odds ratio (OR) was used
as a quantitative measure of the breast cancer risk. Experi-
mental results indicate that the proposed IBBFS method
can identify the complex interactions of the tested SNPs
both in the low and high risk groups. In the future, the
IBBFS method can potentially be applied to SNP-SNP
interactions (epistasis) in other association studies.
Methods
Data sets
The data set was provided by Lin et al. and includes breast
cancer data, SNPs, personal information and clinical data
[2]. This study continues research from a previous study
with 220 case and 334 control breast cancer data sets. The
case control study was conducted at the Kaohsiung Med-
ical University in Taiwan. The data sets were collected
from female patients who came to said hospital for routine
physical checkups or distinctive minor operations. The
SNP name, the number of cases, the number of controls,
and related information is shown in Table 7.ntrols
Scoring function
p-value
SN SP Average Odds Ratio
0.372 0.552 0.469 0.733 (0.503-1.068) 0.10
0.111 0.902 0.526 1.145 (0.536-2.438) 0.72
0.587 0.373 0.474 0.880 (0.594-1.304) 0.57
0.274 0.695 0.357 0.857 (0.478-1.536) 0.68
0.294 0.777 0.552 1.452 (0.962-2.191) 0.07
0.382 0.973 0.659 1.442 (0.421-4.880) 0.57
0.480 0.562 0.524 1.189 (0.822-1.723) 0.37
0.131 0.884 0.537 1.149 (0.550-2.387) 0.73
0.276 0.643 0.472 0.687 (0.463-1.016) 0.05
0.037 0.972 0.528 1.361 (0.381-4.870) 0.77
0.451 0.541 0.499 0.971 (0.670-1.408) 0.93
0.110 0.841 0.510 0.655 (0.316-1.347) 0.25
0.342 0.578 0.469 0.709 (0.484-1.042) 0.08
0.119 0.905 0.531 1.296 (0.622-2.700) 0.08
C: Correct; SN: Sensitivity; SP: Specificity.
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The branch and bound algorithm (BB) is a divide-
and-conquer approach used to solve global optimization
issues [28]. The concept of a BB is based on constructing
a search tree. Only feasible solutions are used and expli-
citly evaluated to detect optimal solutions. A BB algorithm
requires two steps. First, a branching procedure is used
to define the tree structure (the search tree). Then a
bounding procedure that computes upper and lower
bounds for the evaluation value (evaluation nodes) is
implemented. If the next node (lower bound) in the series
does not conform to the evaluation value (set bound
value), the node is cut off. Compared to exhaustive search
(ES), traditional BB algorithms do not guarantee that
enough subtrees are cut off to keep the total number of
criteria computations lower than in the ES method [29].
Under most circumstances, a traditional BB algorithm is
faster than an exhaustive search. However, many redun-
dant searches are still conducted in a BB algorithm [30].
To overcome this problem, Somol proposed the fast
branch and bound algorithm [28] and Chen proposed an
improved branch and bound algorithm for optimal feature
subset selection [30]. Branch and bound algorithms have
been successfully applied in many fields, such as predicting
drug-like compounds [31], analysis of protein–protein
interactions [32], feature selection problems [29] and
data mining problems [33,34]. In addition, branch and
bound performance may be weaker under the following
conditions: (1) Nearer to the root, the criterion value com-
putation is usually slower (evaluated feature subsets are
larger) and (2) nearer to the root, subtree cut-offs are
less frequent (higher criterion values of larger subsets
are compared to the bound, which is updated in the
leaves) [28]. A possible solution tree is introduced in
Additional file 1: Figure S3 and a BB algorithm flowchart
is shown in Additional file 1: Figure S4.
Improved branch and bound algorithm with feature
selection
As previously stated, traditional BB algorithms that
search for all possible combinations are impractical
since the number of combinations increases exponen-
tially as the dimensionality increases [30]. Hence, we
propose the use of a BB algorithm combined with a
feature selection technique to reduce the necessary cal-
culation time. Feature selection algorithms are special
from a theoretical perspective. It can be shown that op-
timal feature selection for supervised learning problems
requires an exhaustive search of all possible subsets of
features of the chosen cardinality [30]. A large number
of features is thus impractical. By using a subset of
features, the processing time required by the classifica-
tion process can be reduced. This improved branch and
bound algorithm has several advantages when combinedwith feature selection (IBBFS). It not only reduces the
search time but, more importantly, also sorts the results
into low and high risk groups (discussed in the bound
evaluation section). The IBBFS algorithm is very efficient
because it avoids exhaustive searches (ES) by rejecting
suboptimal subsets. It also guarantees that a selected sub-
set yields the best global value. A flowchart of this process
is shown in Additional file 1: Figure S5. The IBBFS
pseudo-code is given in below.
IBBFS pseudo-code
B: Defined as 0.
R: Number of features used.
N: Total number of SNPs.
M: Total number of selected SNPs.
AVAIL: List of available feature values that LIST(m) can
assume.
LIST(m): List of the features that can be assumed at
level m.
Φ: Empty set.Step 1: Initialize
Level m=1, AVAIL ={nodem 1, nodem 2,
nodem j, . . ., nodem r | nodem-1 ≠Φ,
r=(n-m+1) × (n-(m-1)), j is the jth node}Step 2: Generate branch
LIST(m)={AVAIL | select top r node based on
their bound value}
If LIST(m) =Φ, go to step 5.Step 3: Select node
Select the rightmost node in LIST(m), i.e., if
nodem j=max(LIST(m)) remove the
rightmost node in LIST(m)Step 4: Calculate bound value
If bound(nodem j) > B, return nodem j to AVAIL
and go to Step 5.
If last node in level m
If level m= higher level, go to Step 6, otherwise,
m=m+1 and go to Step 2.Step 5: Backtrack
If LIST(m) is empty, set m=m-1. If m=0,
terminate the algorithm,
otherwise, go to Step 3.Step 6: Higher level,
Sort nodesm based on bound value
Return best nodem.IBBFS uses top-down and right-left search strategies
together with backtracking. We define the update bound
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controls is 0, the node should be not explored. If the
bound value at a node j at level m is larger than the
current bound value B, then the paths originating from
that node to the bottom of the tree should still be
explored. We select the top r node based on the bound
value for exploration to the next level. Omitting the
evaluation of bound values for a set of successor nodes
(i.e., j < r at some parent nodes) is key to an efficient
IBBFS. Backtracking is used until all successors or nodes
and paths with bounds larger than the current bound
value B have been searched. The computational savings
in the IBBFS occur when the bound value at a node j at
a higher level in the tree is the best value.
Bound evaluation
Statistical epistasis is a population phenomenon that
depends on allele frequencies present in a specific popu-
lation [35]. This study uses the maximum difference of
allele frequencies between case and control groups to
evaluate the bound value. A large difference in the
bound value indicates that certain SNP and genotype
combinations are more likely to occur in breast cancer,
whereas other combinations are associated with a low
cancer risk. We divided the bound calculation into two
separate steps: 1) The total number of SNP combinations
in the control data set is calculated and 2) the total num-
ber of SNP combinations in the case data set is calculated.
Subsequently, Eq. (1) is used to determine the bound
value of each combination to find the maximum differ-
ence.
bound ið Þ ¼
XN
n¼1
Checkcontroln ið Þð Þ 
XC
c¼1
Checkcasec ið Þð Þ
ð1Þ
In Eq. (1), N represents the number of samples in the
control data, and C represents the number of samples in
the case data. Check_controln (i) and Check_casec (i) are
respectively checked as to whether or not the node i (i.e.,
SNP combination) matches the n sample in the control
data and the c sample in the case data. If a match occurs,
Check_controln (i)/ Check_casec (i) is set to 1, otherwise, it
is set to 0.
XN
n¼1
Checkcontrolnð Þ represents the sum of the




represents the sum of the Check_casec (i) from 1 to C. If
the positive maximum bound value is selected as a feature
in the next combination, then the respective OR value
indicates a low cancer risk. On the other hand, if the nega-
tive maximum bound is selected as a feature in the next
combination, then the respective OR value is associatedwith a high cancer risk. The supplementary example
illustrates how the bound values are calculated.
For example, assume that SNPs (3, 4) with genotype
(1–1) are the best SNP combination. SNP3 (rs2228014)
has the three genotypes CC, CT, and TT, which can be
respectively represented as 1, 2, and 3, and SNP4
(rs1801157) has the three genotypes GG, AG, and AA,
which can also be respectively represented as 1, 2, and 3.
We compute the number that matches the condition of
the SNPs and genotypes for the case and control data.
First, we calculate the control number for SNP3 with
genotype 1 and SNP4 with genotype 1. The number of
controls that independently match SNP3 with genotype 1
and SNP4 with genotype 1 are 254 and 175, respectively.
The number of controls that match SNP (3, 4) with geno-
type (1–1) is thus 137. Secondly, we calculate the number
of cases independently matching SNP3 with genotype 1
and SNP4 with genotype 1 as 151 and 106, respectively.
The number of cases that match SNP (3, 4) with genotype
(1–1) is thus 69. According to Eq. (1), the bound value is
determined by subtracting 69 from 137, thus giving 68.Performance measurement
We used four common criteria to determine the best
combinations of SNPs related to the cancer risk, namely
the correctness (CC), the sensitivity (SN), the specificity
(SP) and the odds ratio (OR) [8]. The odds ratio has be-
come widely used in epidemiology and case control
studies. It is a commonly-used statistic that expresses
the strength of association between an exposure and a
disease [36,37] due to the following three facts: 1) OR
provides an estimate (i.e., a confidence interval) for the
relationship between two binary variables; 2) it allows us
to examine the effects of other variables on that relation-
ship via logistic regression; and 3) OR is very con-
venient for interpretation of case–control studies [18].
It corresponds to the effect of each specific SNP–SNP
interaction combination on the occurrence of breast
cancer. The four criteria are defined in Eqs. (2–5), and
the calculation processes are shown in Additional file 1:
Figure S6. Statistical analysis was carried out using
http://statpages.org/ctab2x2.html.
CC ¼ TP þ TN
TP þ FN þ FP þ TN ð2Þ
SN ¼ TP
TP þ FN ð3Þ
SP ¼ TN
TN þ FP ð4Þ
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FN  FP ð5Þ
TP represents the number of true positives, TN
represents the number of true negatives, FN represents
the number of false negatives, and FP represents the
number of false positives.
Illustrative example
The proposed IBBFS algorithm with incorporated feature
selection selects the most promising solution and then
evaluates only the features of the next SNP combinations
of this branch. Furthermore, the algorithm is based on the
expansion of two-SNP combinations, which means that
the two-SNP combination results are used and expanded
until the maximum combination (number of SNPs) is
reached. For example, if the SNP (1, 2) with genotype (2–2)
combinations constitutes the best result (feature), then
combinations of three SNPs that contain SNP (1, 2) with
genotype (2–2) are found in the next step. The expanded
results are SNP (1, 2, 3) with genotype (2-2-1), SNP (1, 2,
3) with genotype (2-2-2), and SNP (1, 2, 3) with genotype
(2-2-3). A detailed example is shown in Additional file 1:
Figure S7. These expanded results reduce the search time
by cutting off unnecessary paths. The update bound value
in this study was set to 0, which means that, if the
numbers of cases and controls are 0, the node is cut off.
In contrast to the BB algorithm, IBBFS only uses selected
features (after sorting the results), which allows it to find
an optimal solution by cutting off unnecessary pathways.
Although the IBBFS algorithm is of a high time complex-
ity for combinations of two SNPs, it performs better for
interaction combinations of a high order. After the best
SNP combinations are found, the OR is used in the next
step to evaluate each best SNP combination with regard
to the susceptibility risk. A simple IBBFS calculation
process is shown in the Additional file 1 section.
In Additional file 1: Figure S3, the different paths from
the top to level 1 indicate that level 1 has 4 SNP paths.
If the node results are 0 (meaning the number of cases
and controls are 0), the node is cut off. Additional file 1:
Figure S3 indicates that the y node is cut off at level 1
(two combinations) because it is terminal. Under the
same criteria, each new terminal combination is cut off.
If the traditional BB algorithm nodes are not cut off, the
calculated time complexity equates that of the ES. The
ES function is as follows:
Xn
m¼2
C n;mð Þ  3m ð6Þ
where n is the total number of SNPs, and m is the number
of selected SNP combinations.When two SNPs are selected and each genotype has
three possible state combinations, ES calculates the num-
ber of possible solutions as C(4,2)*32 =54. Based on the
aforementioned calculation process, the use of traditional
BB algorithms or ES to explore combinations of three,
four or more SNPs is impractical since the increased
number of combinations exponentially increases the time
complexity Simple ES, BB and IBBFS calculation processes
are shown in the Additional file 1 section.
Additional file
Additional file 1: Figure S1. Exhaustive search algorithm calculation
process. Figure S2. Calculation process of the improved branch and
bound feature selection (IBBFS) algorithms. Figure S3. Branch and bound
search tree. Figure S4. Flowchart of a branch and bound algorithm.
Figure S5. Flowchart of the improved branch and bound algorithm
(IBBFS). Figure S6. Performance calculations. Figure S7. Extended SNP
combinations. Supplementary example, include a example for calculation
of the SNP-SNP interaction, Figure S8. Example of a search tree, Figure
S9. Search tree of two-SNP combinations, Table S1. Example data set,
Table S2. Results for two-SNP combinations, Table S3. Results for three-
SNP combinations, Table S4. Results for four-SNP combinations, Table
S5. Table of cases and controls, Table S6. Common criteria, Table S7.
Performance calculation.
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